US Patent

US9032965 — Methods and system for image guided cell ablation with microscopic resolution

Method of Use · Assigned to Lumicell Inc · Expires 2031-12-08 · 6y remaining

Vulnerability score 81/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a system and method for removing diseased cells during surgery with microscopic resolution.

USPTO Abstract

The invention provides systems and method for the removal of diseased cells during surgery.

Drugs covered by this patent

pegulicianine-acetate (PEGULICIANINE ACETATE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3890`	—	pegulicianine-acetate

Patent Metadata

Patent number: US9032965
Jurisdiction: US
Classification: Method of Use
Expires: 2031-12-08
Drug substance claim: No
Drug product claim: No
Assignee: Lumicell Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.